BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 29, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 25, 2020
View Archived Issues
Dosing completed in phase I study of ML-004 as therapy for social deficit in ASD
Read More
Making exceptional responders unexceptional
Read More
Twist reports preclinical data on antibodies against S1 protein in SARS-CoV-2
Read More
FDA approves Xofluza for post-exposure prophylaxis of influenza
Read More
Capricor initiates dosing in phase II study of CAP-1002 in severe COVID-19
Read More
Genmab halts development of enapotamab vedotin
Read More
CTA for first-in-human study of FS-222 receives clearance in Spain
Read More
Cure Biopharma patents gemcitabine prodrugs for cancer
Read More
Incyte discloses new CDK2/cyclin E inhibitors
Read More
Snap Bio presents new Pim-1 and/or Pim-3 kinase inhibitors
Read More
Merck & Co. describes new nicotinic alpha7 receptor PAMs
Read More
Humabs BioMed divulges antibodies targeting influenza A HA protein
Read More
Tremfya approved in E.U. for active psoriatic arthritis
Read More
Final phase I/II data for PLX-9486 plus sunitinib in GIST
Read More
First-in-human data presented for Plasmodium falciparum transmission-blocking MAb
Read More
shMKK4-224: an MKK4 inhibitor for liver regeneration
Read More
Initial first-in-human data on BMS-986218 support further evaluation
Read More
Antimicrobial polymers AMP up fight against MDR bacteria
Read More
Phase III interim data reported on Sputnik V COVID-19 vaccine candidate
Read More
Treating Zika virus in a pregnant nonhuman primate model
Read More
Topline phase IIa data on vibegron in IBS show primary endpoint not met
Read More
FDA approves Oxlumo for primary hyperoxaluria type 1
Read More
